The Attorney General of New York announced a $2.4 million settlement with Stericycle, Inc., one of the nation’s largest medical disposal companies for overcharges top nearly 1,000 municipal entities across the state. Stericycle implemented overcharges by instituting automatic price increases without giving notice. Under the settlement, Stericycle will repay all overcharges to every municipality and agreed not to implement automatic price increases in the future
For more information,
According to a recent article, the SEC, which was the target of lengthy criticism following several botched investigations including the Bernie Madoff scandal, has come a long way. The agency has restructured its division of enforcement, creating five specialized units with employees who have sufficient knowledge of industry segments. According to outgoing Director of Enforcement,
Despite recently pleading guilty in a major Medicare fraud case, Amgen, the world’s largest bio-technology company, received a major gift from Congress in its “fiscal cliff” bill—a delay in Medicare price restraints on a class of drugs that includes Amgen’s profitable Sensipar pill.
Under the provision, Amgen will be able to continue to sell Sensipar,
U.S. District Court judge Terrence Boyle rejected a proposed settlement and deferred prosecution agreement by WakeMed Health and Hospitals, a North Carolina health system criminally charged with ripping off Medicare for at least $1.2 million. The first hospital or health system to be criminally charged with defrauding Medicare, WakeMed Health and Hospitals allegedly made false statements to Medicare in order to be reimbursed for costly inpatient stays of Medicare patients who never actually were inpatients at the hospital.
The Floyd Landis vs. Lance Armstrong FCA complaint is unsealed.
To view the complaint, please see:
http://www.pietragallo.com/library/files/landis-armstrong-usps-complaint_(2).pdf
Michael A. Morse, chair of the national qui tam pracitce group at Pietragallo Gordon Alfano Bosick & Raspanti, LLP, was quoted in an article in today’s LA Times discussing the federal whistleblower lawsuit accusing Lance Armstrong of defrauding the U.S. Postal Service. The suit is filed by former teammate, Floyd Landis.
Chair of Pietragallo’s national qui tam practice group, Michael A. Morse, was quoted in an article in today’s New York Daily News discussing how the legal fate of Lance Armstrong is in the hands of the Department of Justice.
To view the article, please see:
http://www.nydailynews.com/sports/i-team/lance-legal-fate-rests-ag-holder-hands-article-1.1240710#ixzz2I9ohwj2c
A January 13, 2013 Wall Street Journal article detailed a recent development in the federal whistleblower lawsuit aimed at recouping $30.6 million in U.S. Postal Service sponsorship money paid to professional cyclist Lance Armstrong’s team from 2001 to 2004. The U.S. Department of Justice first considering joining the suit since 2010 when it was filed by Armstrong’s former teammate,
On January 4, 2013, the Attorney General for Texas, Greg Abbott, announced that Pfizer, Inc. and Endo Pharmaceuticals will pay $36 million to settle a whistleblower suit filed under Texas’ Medicaid Fraud Prevention Act. The settlement resolves allegations that the companies defrauded Medicaid by misreporting the price of generic drugs for the Medicaid program.
On January 10, 2013, a pharmaceutical company based in San Diego, Victory Pharma, Inc., agreed to pay $11.4 Million to resolve allegations that it improperly marketed its pharmaceutical products. It is alleged that Victory violated the federal Anti-Kickback Statute and False Claims Act by paying kickbacks to doctors who prescribe the company’s drugs.
